17 research outputs found
The significance of immunohistochemistry positivity in sentinel nodes which are negative on haematoxylin and eosin in breast cancer
Strong absorption and ultrafast localisation in NaBiS2 nanocrystals with slow charge carrier recombination
I V VI2 ternary chalcogenides are gaining attention as earth abundant, nontoxic, and air stable absorbers for photovoltaic applications. However, the semiconductors explored thus far have slowly rising absorption onsets, and their charge carrier transport is not well understood yet. Herein, we investigate cation disordered NaBiS2 nanocrystals, which have a steep absorption onset, with absorption coefficients reaching gt;105 cm amp; 8722;1 just above its pseudo direct bandgap of 1.4 eV. Surprisingly, we also observe an ultrafast picosecond time scale photoconductivity decay and long lived charge carrier population persisting for over onemicrosecond in NaBiS2 nanocrystals. These unusual features arise because of the localised, non bonding S p character of the upper valence band, which leads to a high density of electronic states at the band edges, ultrafast localisation of spatially separated electrons and holes, as well as the slow decay of trapped holes. Thiswork reveals the critical role of cation disorder in these systems on both absorption characteristics and charge carrier kinetic
Age at first birth in women is genetically associated with increased risk of schizophrenia
Prof. Paunio on PGC:n jäsenPrevious studies have shown an increased risk for mental health problems in children born to both younger and older parents compared to children of average-aged parents. We previously used a novel design to reveal a latent mechanism of genetic association between schizophrenia and age at first birth in women (AFB). Here, we use independent data from the UK Biobank (N = 38,892) to replicate the finding of an association between predicted genetic risk of schizophrenia and AFB in women, and to estimate the genetic correlation between schizophrenia and AFB in women stratified into younger and older groups. We find evidence for an association between predicted genetic risk of schizophrenia and AFB in women (P-value = 1.12E-05), and we show genetic heterogeneity between younger and older AFB groups (P-value = 3.45E-03). The genetic correlation between schizophrenia and AFB in the younger AFB group is -0.16 (SE = 0.04) while that between schizophrenia and AFB in the older AFB group is 0.14 (SE = 0.08). Our results suggest that early, and perhaps also late, age at first birth in women is associated with increased genetic risk for schizophrenia in the UK Biobank sample. These findings contribute new insights into factors contributing to the complex bio-social risk architecture underpinning the association between parental age and offspring mental health.Peer reviewe
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome